NASDAQ:GNLNGreenlane Stock Price, Forecast & News

Greenlane's stock was trading at $1.44 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, GNLN stock has increased by 150.7% and is now trading at $3.61. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Greenlane in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Greenlane.

Greenlane is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020. View our earnings forecast for Greenlane.

Greenlane Holdings (NASDAQ:GNLN) announced its quarterly earnings data on Thursday, June, 4th. The company reported ($0.58) EPS for the quarter, missing analysts' consensus estimates of ($0.15) by $0.43. The business had revenue of $33.87 million for the quarter, compared to the consensus estimate of $32.52 million. Greenlane had a negative return on equity of 13.44% and a negative net margin of 8.32%. View Greenlane's earnings history.

3 brokers have issued 1-year price objectives for Greenlane's shares. Their forecasts range from $4.00 to $5.00. On average, they anticipate Greenlane's share price to reach $4.33 in the next year. This suggests a possible upside of 20.0% from the stock's current price. View analysts' price targets for Greenlane.

News articles about GNLN stock have trended somewhat negative recently, according to InfoTrie. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Greenlane earned a daily sentiment score of -1.8 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news about Greenlane.

Some companies that are related to Greenlane include Mandom (MDOMF), Fresh Del Monte Produce (FDP), Calavo Growers (CVGW), Scholastic (SCHL), Universal (UVV), Schweitzer-Mauduit International (SWM), United Natural Foods (UNFI), John B. Sanfilippo & Son (JBSS), Purple Innovation (PRPL), e.l.f. Beauty (ELF), Celsius (CELH), PREMIER FOODS P/ADR (PRRFY), Greencore Group (GNCGY), Meredith (MDP) and MGP Ingredients (MGPI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Greenlane investors own include Ovid Therapeutics (OVID), Curaleaf (CURLF), Enphase Energy (ENPH), KushCo (KSHB), Aurora Cannabis (ACB), Inovio Pharmaceuticals (INO), Roku (ROKU), Walt Disney (DIS), Trulieve Cannabis (TCNNF) and Energy Transfer LP Unit (ET).

(GNLN) raised $80 million in an initial public offering (IPO) on Thursday, April 18th 2019. The company issued 5,300,000 shares at a price of $14.00-$16.00 per share. Cowen and Company and Canaccord Genuity acted as the underwriters for the IPO and Ladenburg Thalmann, Roth Capital Partners and Northland Securities were co-managers.

Greenlane trades on the NASDAQ under the ticker symbol "GNLN."

Shares of GNLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of GNLN stock can currently be purchased for approximately $3.61.

Greenlane has a market capitalization of $339.15 million and generates $185.01 million in revenue each year. The company earns $-28,820,000.00 in net income (profit) each year or $0.36 on an earnings per share basis. Greenlane employs 249 workers across the globe.

The official website for Greenlane is www.gnln.com.

Greenlane's mailing address is 1095 BROKEN SOUND PARKWAY SUITE 300, BOCA RATON FL, 33487. The company can be reached via phone at 877-292-7660 or via email at [email protected]